Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome

The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma,...

Full description

Saved in:
Bibliographic Details
Published in:Case Rep Oncol Med
Main Authors: Chaucer, Benjamin, Stone, Abriella, Demanes, Augustus, Seibert, Shawn M.
Format: Artigo
Language:Inglês
Published: Hindawi 2018
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822822/
https://ncbi.nlm.nih.gov/pubmed/29593922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4273231
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items